Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Jun 01, 2006 (Vol. 26, No. 11)

French Biotech Database

URL:www.frenchbiotech.com/frenchbiotech/index.php
  • Much information
  • Uninspired
Want to know more about french biotechnology companies? Of course you do! Just for you then, the French Biotech Database is ready and waiting to serve. Assembled by a company called Venture Valuation, the French Biotech Database site provides visitors with free access to extensive company information by a variety of means. The first is a search engine that can be accessed by simple and advanced means. Alternatively, one can view alphabetical listings of companies (and there are a lot). Companies are organized in categories that include Biotechnology, Instrumentation/Services, Biotech Related, Medical Technology, and others. Though the site is not overly inspired, the information is plentiful.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »